ea0035p549 | Endocrine tumours and neoplasia | ECE2014
Iacovazzo Donato
, Lugli Francesca
, Bianchi Antonio
, Capoluongo Ettore
, Lucci-Cordisco Emanuela
, Persiani Roberto
, Doglietto Giovanni Battista
, Pontecorvi Alfredo
, Rindi Guido
, De Marinis Laura
GEP NETs, especially gastrinomas, occur in 4070% of MEN1 patients and represent the main cause of death in these patients.We aim to investigate the efficacy of lanreotide autogel (ATG) in the treatment of MEN1-related gastrinomas.We report a monocentric series of seven MEN1 patients (three M, and four F) treated with lanreotide ATG (120 mg/4 weeks) for a mean period of 62.1 months. Plasma gastrin levels have been measured at ...